Bienvenue aux Nations Unies
Langue：
  1. Accueil ONU
  2. Drug treatment in Oceania

Drug treatment in Oceania

Submitted by URAHMONB on 20 June 2018 - 9:38am

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN OCEANIA

2016 (or latest year available)

 

Country / Territory

 

Source

 

Treatment
Year ***

Distribution of main drugs in percentages*

 

Treatment
Provided **

 

Data
Primarily
Reflect

Cannabis

Opioids

Cocaine

ATS

Tranquilizers
and Sedatives

Hallucinogens

Solvents
and  Inhalants

Other †

Australia

ARQ

2015

29.4%

7.4%

 

24.2%

1.5%

 

 

 

133,895

k, c

New Zealand

DAINAP/ARQ

2011/2016***

49.6%

42.0%

0.5%

6.5%

0.0%

1.5%

0.0%

0.0%

45,684

a

Fiji ††

DAINAP

2006

87.2%

0.0%

0.0%

0.0%

12.8%

0.0%

0.0%

0.0%

312

f

Total

    

 

 

 

 

 

 

 

 

179,579

 

Average

 

 

48.3%

26.9%

0.3%

22.6%

1.2%

0.8%

-

-

 

 

 

*      Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 per cent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs. In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.

**    Figures may reflect number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine.

***  If multiple years are given, the second year specified is for the number of people treated (second to last column).

†    In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.

††     Fiji is excluded because of the disproportionate affect that the small number in treatment has on the unweighted mean

  1. Whole country
  2. Geographically limited reporting (eg the Capital city)
  3. Publicly funded treatment
  4. NGO/ privately funded treatment
  5. Inpatient/ hospitalization modality
  6. Outpatient modality
  7. Limited subpopulation (eg prison, youth, etc)
  8. Opioid substitution treatment (eg methadone)
  9. First-time treatment entrants (not returning clients)
  10. Treatment admissions (not persons)
  11. Partial coverage (geographical/treatment type)
  12. Prisons excluded
  13. Treatment entrants only